Banxia Xiexin Decoction delays colitis-to-cancer transition by inhibiting E-cadherin/β-catenin pathway via Fusobacterium nucleatum FadA-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Banxia Xiexin Decoction delays colitis-to-cancer transition by inhibiting E-cadherin/β-catenin pathway via Fusobacterium nucleatum FadA

Published:2024-06 Issue: Volume:328 Page:117932
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Jiang Yifang,Huang Yuqing,Hu Yane,Yang Yi,You Fengming,Hu Qiongying,Li Xueke,Zhao Ziyi

Funder

National Natural Science Foundation of China

Chengdu University of Traditional Chinese Medicine

Publisher

Elsevier BV

Reference65 articles.

1. Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc;Abed;Cell Host Microbe,2016

2. Macrophage depletion using clodronate liposomes decreases tumorigenesis and alters gut microbiota in the AOM/DSS mouse model of colon cancer;Bader;Am. J. Physiol. Gastrointest. Liver Physiol.,2018

3. Evidence accumulates indicating periodontal disease as a risk factor for colorectal cancer or lymphoma;Barton;CA Cancer J. Clin.,2017

4. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium;Brennan;Nat. Rev. Microbiol.,2019

5. Efficacy of Banxia Xiexin Decoction for chronic atrophic gastritis: a systematic review and meta-analysis;Cao;PLoS One,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fusobacterium periodonticum BCT protein targeting glucose metabolism to promote the epithelial-mesenchymal transition of esophageal cancer cells by lactic acid;Journal of Translational Medicine;2024-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP